185 related articles for article (PubMed ID: 11959788)
1. Aponecrotic, antiangiogenic and antiproliferative effects of a novel dextran derivative on breast cancer growth in vitro and in vivo.
Di Benedetto M; Starzec A; Colombo BM; Briane D; Perret GY; Kraemer M; Crépin M
Br J Pharmacol; 2002 Apr; 135(8):1859-71. PubMed ID: 11959788
[TBL] [Abstract][Full Text] [Related]
2. Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice.
Di Benedetto M; Kourbali Y; Starzec A; Vassy R; Jozefonvicz J; Perret G; Crepin M; Kraemer M
Br J Cancer; 2001 Sep; 85(6):917-23. PubMed ID: 11556846
[TBL] [Abstract][Full Text] [Related]
3. Cytostatic and pro-apoptotic effects of a novel phenylacetate-dextran derivative (NaPaC) on breast cancer cells in interactions with endothelial cells.
Malherbe S; Crépin M; Legrand C; Wei MX
Anticancer Drugs; 2004 Nov; 15(10):975-81. PubMed ID: 15514567
[TBL] [Abstract][Full Text] [Related]
4. Sodium phenylacetate modulates the synthesis of autocrine and paracrine growth factors secreted by breast cancer cell lines.
Thibout D; Di Benedetto M; Kraemer M; Sainte-Catherine O; Derbin C; Crépin M
Anticancer Res; 1998; 18(4A):2657-61. PubMed ID: 9703924
[TBL] [Abstract][Full Text] [Related]
5. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.
Adam L; Crépin M; Isräel L
Cancer Res; 1997 Mar; 57(6):1023-9. PubMed ID: 9067263
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: blockage of the paracrine effect and receptor binding of transforming growth factor beta1 and platelet-derived growth factor-BB.
Bagheri-Yarmand R; Kourbali Y; Morère JF; Jozefonvicz J; Crépin M
Cell Growth Differ; 1998 Jun; 9(6):497-504. PubMed ID: 9663468
[TBL] [Abstract][Full Text] [Related]
7. Sodium phenylacetate (NaPa) induces modifications of the proliferation, the adhesion and the cell cycle of tumoral epithelial breast cells.
Thibout D; Kraemer M; Di Benedetto M; Saffar L; Gattegno L; Derbin C; Crépin M
Anticancer Res; 1999; 19(3A):2121-6. PubMed ID: 10470159
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of human melanoma tumor cells by the combination of sodium phenylacetate (NaPA) and substituted dextrans and one NaPA-dextran conjugate.
Gervelas C; Avramoglou T; Crépin M; Jozefonvicz J
Anticancer Drugs; 2002 Jan; 13(1):37-45. PubMed ID: 11914639
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative.
Di Benedetto M; Starzec A; Vassy R; Perret GY; Crépin M; Kraemer M
Br J Cancer; 2003 Jun; 88(12):1987-94. PubMed ID: 12799647
[TBL] [Abstract][Full Text] [Related]
10. A new phenylacetate-bisphosphonate inhibits breast cancer cell growth by proapoptotic and antiangiogenic effects.
Sebbah-Louriki M; Colombo BM; el Manouni D; Martin A; Salzmann JL; Leroux Y; Perret GY; Crépin M
Anticancer Res; 2002; 22(6C):3925-31. PubMed ID: 12553014
[TBL] [Abstract][Full Text] [Related]
11. Decrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive molecules.
Vasse M; Thibout D; Paysant J; Legrand E; Soria C; Crépin M
Br J Cancer; 2001 Mar; 84(6):802-7. PubMed ID: 11259095
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative and antitumoral activities of a functionalized dextran (CMDBJ) on the 1205 L-U human tumor melanoma cells.
Bastias J; Wei MX; Huynh R; Chaubet F; Jozefonvicz J; Crepin M
Anticancer Res; 2002; 22(3):1603-13. PubMed ID: 12168844
[TBL] [Abstract][Full Text] [Related]
13. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
14. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
15. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases are involved in both type I (apoptosis) and type II (autophagy) cell death induced by sodium phenylacetate in MDA-MB-231 breast tumour cells.
Augustin S; Berard M; Kellaf S; Peyri N; Fauvel-Lafève F; Legrand C; He L; Crépin M
Anticancer Res; 2009 Apr; 29(4):1335-43. PubMed ID: 19414384
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro.
Ferrandina G; Melichar B; Loercher A; Verschraegen CF; Kudelka AP; Edwards CL; Scambia G; Kavanagh JJ; Abbruzzese JL; Freedman RS
Cancer Res; 1997 Oct; 57(19):4309-15. PubMed ID: 9331092
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of MCF-7 tumor cell line by phenylacetate linked to functionalized dextran.
Frank L; Avramoglou T; Sainte-Catherine O; Jozefonvicz J; Kraemer M
J Biomater Sci Polym Ed; 2004; 15(10):1305-15. PubMed ID: 15559851
[TBL] [Abstract][Full Text] [Related]
19. The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7).
Bagheri-Yarmand R; Kourbali Y; Mabilat C; Morère JF; Martin A; Lu H; Soria C; Jozefonvicz J; Crépin M
Br J Cancer; 1998 Jul; 78(1):111-8. PubMed ID: 9662260
[TBL] [Abstract][Full Text] [Related]
20. Sodium phenylacetate induces growth inhibition and Bcl-2 down-regulation and apoptosis in MCF7ras cells in vitro and in nude mice.
Adam L; Crépin M; Savin C; Israël L
Cancer Res; 1995 Nov; 55(22):5156-60. PubMed ID: 7585564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
